

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfation (GO:0051923) | 7.00040877 |
| 2 | negative regulation of protein autophosphorylation (GO:0031953) | 5.40168106 |
| 3 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.38353737 |
| 4 | desmosome organization (GO:0002934) | 5.37531853 |
| 5 | establishment of protein localization to Golgi (GO:0072600) | 5.29488417 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 5.07823199 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 5.07823199 |
| 8 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.93870072 |
| 9 | venous blood vessel morphogenesis (GO:0048845) | 4.93576130 |
| 10 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 4.90819076 |
| 11 | citrulline biosynthetic process (GO:0019240) | 4.89622555 |
| 12 | cell migration involved in heart development (GO:0060973) | 4.85101749 |
| 13 | regulation of cholesterol homeostasis (GO:2000188) | 4.79805233 |
| 14 | negative regulation of cell size (GO:0045792) | 4.76129594 |
| 15 | biotin metabolic process (GO:0006768) | 4.71810139 |
| 16 | plasma membrane fusion (GO:0045026) | 4.70059331 |
| 17 | hair cycle (GO:0042633) | 4.68250791 |
| 18 | molting cycle (GO:0042303) | 4.68250791 |
| 19 | activation of Rac GTPase activity (GO:0032863) | 4.60874124 |
| 20 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.58306344 |
| 21 | branching involved in prostate gland morphogenesis (GO:0060442) | 4.56688607 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51238883 |
| 23 | negative regulation of cholesterol transport (GO:0032375) | 4.50917370 |
| 24 | negative regulation of sterol transport (GO:0032372) | 4.50917370 |
| 25 | endothelial cell chemotaxis (GO:0035767) | 4.44889686 |
| 26 | proline biosynthetic process (GO:0006561) | 4.21963012 |
| 27 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 4.18348850 |
| 28 | regulation of receptor binding (GO:1900120) | 4.16418845 |
| 29 | intestinal epithelial cell development (GO:0060576) | 4.15386523 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.15263354 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 4.15263354 |
| 32 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.14133327 |
| 33 | protein carboxylation (GO:0018214) | 4.11664315 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.11664315 |
| 35 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.06627277 |
| 36 | hemidesmosome assembly (GO:0031581) | 3.96457978 |
| 37 | regulation of water loss via skin (GO:0033561) | 3.95803721 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.95645345 |
| 39 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.92401799 |
| 40 | pantothenate metabolic process (GO:0015939) | 3.92154451 |
| 41 | maternal placenta development (GO:0001893) | 3.87917324 |
| 42 | carnitine shuttle (GO:0006853) | 3.87029544 |
| 43 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.85069479 |
| 44 | aromatic amino acid family catabolic process (GO:0009074) | 3.84323500 |
| 45 | bile acid biosynthetic process (GO:0006699) | 3.82977471 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.82936504 |
| 47 | semaphorin-plexin signaling pathway (GO:0071526) | 3.78268460 |
| 48 | regulation of fibrinolysis (GO:0051917) | 3.76177973 |
| 49 | lipid translocation (GO:0034204) | 3.72073006 |
| 50 | phospholipid translocation (GO:0045332) | 3.72073006 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.71459541 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.71459541 |
| 53 | cell-cell junction maintenance (GO:0045217) | 3.69737377 |
| 54 | ear development (GO:0043583) | 3.69149749 |
| 55 | epithelial cell maturation (GO:0002070) | 3.67403715 |
| 56 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67355119 |
| 57 | prostate gland epithelium morphogenesis (GO:0060740) | 3.66251295 |
| 58 | myelin maintenance (GO:0043217) | 3.64334672 |
| 59 | regulation of protein activation cascade (GO:2000257) | 3.62001761 |
| 60 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.61883327 |
| 61 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.61058921 |
| 62 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.60515934 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.58061279 |
| 64 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.57948450 |
| 65 | apoptotic process involved in morphogenesis (GO:0060561) | 3.57253241 |
| 66 | complement activation, alternative pathway (GO:0006957) | 3.56612600 |
| 67 | establishment of skin barrier (GO:0061436) | 3.56152541 |
| 68 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.54767347 |
| 69 | positive regulation of histone deacetylation (GO:0031065) | 3.53403261 |
| 70 | kynurenine metabolic process (GO:0070189) | 3.52737665 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52719555 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52719555 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.48126520 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 3.48126520 |
| 75 | tryptophan catabolic process (GO:0006569) | 3.48126520 |
| 76 | regulation of complement activation (GO:0030449) | 3.46197263 |
| 77 | phosphate ion transport (GO:0006817) | 3.44420139 |
| 78 | urea cycle (GO:0000050) | 3.42496104 |
| 79 | urea metabolic process (GO:0019627) | 3.42496104 |
| 80 | purine ribonucleotide transport (GO:0015868) | 3.39734920 |
| 81 | alpha-linolenic acid metabolic process (GO:0036109) | 3.39159911 |
| 82 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.38152526 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.36463881 |
| 84 | regulation of RNA export from nucleus (GO:0046831) | 3.35470525 |
| 85 | multicellular organismal water homeostasis (GO:0050891) | 3.33707672 |
| 86 | negative regulation of protein activation cascade (GO:2000258) | 3.33335078 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.30761859 |
| 88 | histone H2A acetylation (GO:0043968) | 3.30623457 |
| 89 | thioester biosynthetic process (GO:0035384) | 3.30232559 |
| 90 | acyl-CoA biosynthetic process (GO:0071616) | 3.30232559 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28391921 |
| 92 | sulfur amino acid catabolic process (GO:0000098) | 3.26900056 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.23816652 |
| 94 | sensory perception of taste (GO:0050909) | 3.22956428 |
| 95 | phospholipid efflux (GO:0033700) | 3.22441067 |
| 96 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22310003 |
| 97 | glyoxylate metabolic process (GO:0046487) | 3.22234232 |
| 98 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.21645147 |
| 99 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.20745391 |
| 100 | heme transport (GO:0015886) | 3.19188247 |
| 101 | proline metabolic process (GO:0006560) | 3.18287151 |
| 102 | nitrogen cycle metabolic process (GO:0071941) | 3.16127725 |
| 103 | negative regulation of cell fate commitment (GO:0010454) | 3.15794333 |
| 104 | epithelial cell-cell adhesion (GO:0090136) | 3.14099095 |
| 105 | complement activation (GO:0006956) | 3.10717444 |
| 106 | citrulline metabolic process (GO:0000052) | 3.10668453 |
| 107 | purine nucleotide transport (GO:0015865) | 3.10566791 |
| 108 | bile acid metabolic process (GO:0008206) | 3.09708634 |
| 109 | tryptophan metabolic process (GO:0006568) | 3.09519394 |
| 110 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 3.09386859 |
| 111 | very long-chain fatty acid metabolic process (GO:0000038) | 3.08304167 |
| 112 | negative regulation of monooxygenase activity (GO:0032769) | 3.07887044 |
| 113 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.07319040 |
| 114 | protein retention in ER lumen (GO:0006621) | 3.05256545 |
| 115 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.04884858 |
| 116 | lung epithelial cell differentiation (GO:0060487) | 3.03125896 |
| 117 | cell junction maintenance (GO:0034331) | 3.01925465 |
| 118 | oxaloacetate metabolic process (GO:0006107) | 3.01678693 |
| 119 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.01078745 |
| 120 | regulation of cholesterol storage (GO:0010885) | 2.99223329 |
| 121 | lung cell differentiation (GO:0060479) | 2.98142328 |
| 122 | fatty acid elongation (GO:0030497) | 2.97624375 |
| 123 | phosphate ion transmembrane transport (GO:0035435) | 2.97592352 |
| 124 | regulation of triglyceride catabolic process (GO:0010896) | 2.96325495 |
| 125 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.96200206 |
| 126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94870914 |
| 127 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.94463519 |
| 128 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.94463519 |
| 129 | protein activation cascade (GO:0072376) | 2.93304958 |
| 130 | negative regulation of complement activation (GO:0045916) | 2.93107135 |
| 131 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.93093050 |
| 132 | ribosomal small subunit assembly (GO:0000028) | 2.91860288 |
| 133 | fibrinolysis (GO:0042730) | 2.90923595 |
| 134 | opsonization (GO:0008228) | 2.90749335 |
| 135 | adherens junction assembly (GO:0034333) | 2.89972974 |
| 136 | mitochondrion localization (GO:0051646) | 2.89333040 |
| 137 | short-chain fatty acid metabolic process (GO:0046459) | 2.87931157 |
| 138 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.87915612 |
| 139 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.86833185 |
| 140 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.85987712 |
| 141 | histone H3-K36 demethylation (GO:0070544) | 2.85200616 |
| 142 | carnitine transmembrane transport (GO:1902603) | 2.84656333 |
| 143 | plasma lipoprotein particle clearance (GO:0034381) | 2.82568987 |
| 144 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.81856459 |
| 145 | ethanol oxidation (GO:0006069) | 2.81069988 |
| 146 | homocysteine metabolic process (GO:0050667) | 2.80229067 |
| 147 | regulation of viral release from host cell (GO:1902186) | 2.79870436 |
| 148 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.79693583 |
| 149 | glandular epithelial cell differentiation (GO:0002067) | 2.78439541 |
| 150 | * peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.78097307 |
| 151 | vitamin D metabolic process (GO:0042359) | 2.77964011 |
| 152 | water homeostasis (GO:0030104) | 2.77700661 |
| 153 | apical protein localization (GO:0045176) | 2.76951192 |
| 154 | cell-substrate adherens junction assembly (GO:0007045) | 2.76108091 |
| 155 | focal adhesion assembly (GO:0048041) | 2.76108091 |
| 156 | response to testosterone (GO:0033574) | 2.76079747 |
| 157 | establishment of apical/basal cell polarity (GO:0035089) | 2.74391080 |
| 158 | response to lipoprotein particle (GO:0055094) | 2.74337731 |
| 159 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.73971514 |
| 160 | fatty acid beta-oxidation (GO:0006635) | 2.71998149 |
| 161 | vesicle targeting (GO:0006903) | 2.71895700 |
| 162 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.71718410 |
| 163 | fatty acid transmembrane transport (GO:1902001) | 2.71458692 |
| 164 | cysteine metabolic process (GO:0006534) | 2.71231570 |
| 165 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.71110322 |
| 166 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.69588406 |
| 167 | positive regulation of protein deacetylation (GO:0090312) | 2.68470074 |
| 168 | amino-acid betaine metabolic process (GO:0006577) | 2.68094875 |
| 169 | mitochondrion degradation (GO:0000422) | 2.66468786 |
| 170 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.64406760 |
| 171 | negative regulation of viral release from host cell (GO:1902187) | 2.64343928 |
| 172 | regulation of humoral immune response (GO:0002920) | 2.64291161 |
| 173 | regulation of hypersensitivity (GO:0002883) | 2.64242981 |
| 174 | fatty acid catabolic process (GO:0009062) | 2.63995466 |
| 175 | artery development (GO:0060840) | 2.63264088 |
| 176 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.62784315 |
| 177 | pharyngeal system development (GO:0060037) | 2.62768957 |
| 178 | corticosteroid receptor signaling pathway (GO:0031958) | 2.61387089 |
| 179 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.61041111 |
| 180 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.60729462 |
| 181 | regulation of actin nucleation (GO:0051125) | 2.59968683 |
| 182 | acylglycerol homeostasis (GO:0055090) | 2.59666081 |
| 183 | triglyceride homeostasis (GO:0070328) | 2.59666081 |
| 184 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.59558128 |
| 185 | positive thymic T cell selection (GO:0045059) | 2.59109258 |
| 186 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.58761127 |
| 187 | blood coagulation, intrinsic pathway (GO:0007597) | 2.58758291 |
| 188 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.58733927 |
| 189 | cell-substrate junction assembly (GO:0007044) | 2.58582524 |
| 190 | glutamate metabolic process (GO:0006536) | 2.58468007 |
| 191 | ethanol metabolic process (GO:0006067) | 2.58263237 |
| 192 | trivalent inorganic anion homeostasis (GO:0072506) | 2.58036577 |
| 193 | virion attachment to host cell (GO:0019062) | 2.57985672 |
| 194 | adhesion of symbiont to host cell (GO:0044650) | 2.57985672 |
| 195 | response to phenylpropanoid (GO:0080184) | 2.56884167 |
| 196 | fatty acid oxidation (GO:0019395) | 2.56522403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.10826956 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.36270328 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.87703281 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.80264996 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.66978880 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.09839055 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.98416556 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.97340398 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.96165090 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.89941382 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.66722358 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.63520323 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.57513607 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.41195907 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.27543641 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.21156376 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18333418 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13686391 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09043082 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02172166 |
| 21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.91926804 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91380429 |
| 23 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.90136560 |
| 24 | * P68_20966046_ChIP-Seq_HELA_Human | 1.84961084 |
| 25 | KDM2B_26808549_Chip-Seq_K562_Human | 1.79781530 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76806679 |
| 27 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.76148334 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.74489090 |
| 29 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.74384638 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72093907 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71899504 |
| 32 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.71353578 |
| 33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.68233517 |
| 34 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.67685958 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.65170590 |
| 36 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.64992417 |
| 37 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.63016807 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59984803 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59388035 |
| 40 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.54525854 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53693397 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51258534 |
| 43 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51166527 |
| 44 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.50609967 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.46713237 |
| 46 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43919175 |
| 47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43097481 |
| 48 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41078544 |
| 49 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39213697 |
| 50 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.36265931 |
| 51 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.35094513 |
| 52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.33457287 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32780410 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32615309 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30703634 |
| 56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29898453 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29746571 |
| 58 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29151574 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28064749 |
| 60 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.27916569 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27667237 |
| 62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26156065 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25920928 |
| 64 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25565606 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24889059 |
| 66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24754778 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24293083 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22178845 |
| 69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21753008 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20218811 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20037880 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18321822 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16794621 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15458019 |
| 75 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14635140 |
| 76 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.14524414 |
| 77 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.13783047 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13299881 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12965879 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11963243 |
| 81 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11329715 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11174440 |
| 83 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.10834539 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10551614 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09681841 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08454257 |
| 87 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.08292607 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07943618 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.07107345 |
| 90 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.07056996 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.06820490 |
| 92 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06617204 |
| 93 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06307064 |
| 94 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06227220 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05702847 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05531890 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05525263 |
| 98 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05197109 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04748457 |
| 100 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04538372 |
| 101 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04194517 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03705111 |
| 103 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03030935 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02222197 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00294967 |
| 106 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99748968 |
| 107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99495894 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98607172 |
| 109 | * MAF_26560356_Chip-Seq_TH1_Human | 0.98259528 |
| 110 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98002938 |
| 111 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97872009 |
| 112 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97607169 |
| 113 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97270120 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97239541 |
| 115 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.97145135 |
| 116 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96833059 |
| 117 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.96563827 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96369859 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96291315 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95839287 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95300405 |
| 122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94544619 |
| 123 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94144812 |
| 124 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93621468 |
| 125 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93305856 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93247261 |
| 127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92943684 |
| 128 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.92925333 |
| 129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92654173 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92599637 |
| 131 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92420064 |
| 132 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91538795 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91292230 |
| 134 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90678554 |
| 135 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90130880 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89541143 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88954066 |
| 138 | SA1_27219007_Chip-Seq_Bcells_Human | 0.88747303 |
| 139 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.88004669 |
| 140 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87651545 |
| 141 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87339258 |
| 142 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86426903 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86104478 |
| 144 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85973271 |
| 145 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85347784 |
| 146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.85111279 |
| 147 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83958672 |
| 148 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83862931 |
| 149 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83599119 |
| 150 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83066384 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81963460 |
| 152 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81620702 |
| 153 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80389420 |
| 154 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80267653 |
| 155 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79607559 |
| 156 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78436116 |
| 157 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78346721 |
| 158 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78322827 |
| 159 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77858958 |
| 160 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77728243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000537_abnormal_urethra_morphology | 4.13478593 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.04649439 |
| 3 | MP0002254_reproductive_system_inflammat | 3.96222542 |
| 4 | MP0005360_urolithiasis | 3.87637169 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.86803635 |
| 6 | MP0002796_impaired_skin_barrier | 3.78855222 |
| 7 | MP0005365_abnormal_bile_salt | 3.42205637 |
| 8 | MP0004858_abnormal_nervous_system | 3.20051319 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.16920013 |
| 10 | MP0005310_abnormal_salivary_gland | 3.06773005 |
| 11 | MP0001873_stomach_inflammation | 2.87482529 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.82215251 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.65108584 |
| 14 | MP0009840_abnormal_foam_cell | 2.56239934 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.53769849 |
| 16 | MP0003252_abnormal_bile_duct | 2.41781006 |
| 17 | MP0005410_abnormal_fertilization | 2.39246204 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36978781 |
| 19 | MP0008961_abnormal_basal_metabolism | 2.33334592 |
| 20 | MP0000383_abnormal_hair_follicle | 2.33246866 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.27922264 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.23932418 |
| 23 | MP0001348_abnormal_lacrimal_gland | 2.22012045 |
| 24 | MP0000685_abnormal_immune_system | 2.15821598 |
| 25 | MP0003315_abnormal_perineum_morphology | 2.11818285 |
| 26 | MP0005501_abnormal_skin_physiology | 2.11149464 |
| 27 | MP0002006_tumorigenesis | 2.06731413 |
| 28 | MP0002098_abnormal_vibrissa_morphology | 2.04713795 |
| 29 | MP0010329_abnormal_lipoprotein_level | 2.01559031 |
| 30 | MP0010678_abnormal_skin_adnexa | 1.99144698 |
| 31 | MP0000579_abnormal_nail_morphology | 1.97408367 |
| 32 | MP0000647_abnormal_sebaceous_gland | 1.95179731 |
| 33 | MP0000377_abnormal_hair_follicle | 1.93428945 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.89503927 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.85839424 |
| 36 | MP0005409_darkened_coat_color | 1.85234454 |
| 37 | MP0002060_abnormal_skin_morphology | 1.83133997 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.81481908 |
| 39 | MP0003941_abnormal_skin_development | 1.79832644 |
| 40 | MP0001849_ear_inflammation | 1.77048463 |
| 41 | MP0000566_synostosis | 1.77043646 |
| 42 | MP0004947_skin_inflammation | 1.73263753 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.69442790 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.69024721 |
| 45 | MP0001216_abnormal_epidermal_layer | 1.61999856 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.61472697 |
| 47 | MP0010771_integument_phenotype | 1.56741716 |
| 48 | MP0001790_abnormal_immune_system | 1.56080579 |
| 49 | MP0005387_immune_system_phenotype | 1.56080579 |
| 50 | MP0005275_abnormal_skin_tensile | 1.54385712 |
| 51 | MP0002249_abnormal_larynx_morphology | 1.54329004 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.53231178 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.53202110 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.50529679 |
| 55 | MP0004381_abnormal_hair_follicle | 1.49952052 |
| 56 | MP0002089_abnormal_postnatal_growth/wei | 1.47177496 |
| 57 | MP0005083_abnormal_biliary_tract | 1.47085725 |
| 58 | MP0003303_peritoneal_inflammation | 1.45277029 |
| 59 | MP0009379_abnormal_foot_pigmentation | 1.43752114 |
| 60 | MP0001243_abnormal_dermal_layer | 1.43170645 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.41879470 |
| 62 | MP0005367_renal/urinary_system_phenotyp | 1.35225777 |
| 63 | MP0000516_abnormal_urinary_system | 1.35225777 |
| 64 | MP0002234_abnormal_pharynx_morphology | 1.35167007 |
| 65 | MP0003123_paternal_imprinting | 1.32333862 |
| 66 | MP0003283_abnormal_digestive_organ | 1.30530994 |
| 67 | MP0000467_abnormal_esophagus_morphology | 1.28651380 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.28461562 |
| 69 | MP0005670_abnormal_white_adipose | 1.26131672 |
| 70 | MP0001958_emphysema | 1.26054307 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.24998551 |
| 72 | MP0000367_abnormal_coat/_hair | 1.24814728 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.24263750 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.24263750 |
| 75 | MP0001800_abnormal_humoral_immune | 1.24123695 |
| 76 | MP0004130_abnormal_muscle_cell | 1.24059420 |
| 77 | MP0003724_increased_susceptibility_to | 1.22253013 |
| 78 | MP0003638_abnormal_response/metabolism_ | 1.20617636 |
| 79 | MP0002166_altered_tumor_susceptibility | 1.19487923 |
| 80 | MP0001666_abnormal_nutrient_absorption | 1.15756132 |
| 81 | MP0005671_abnormal_response_to | 1.15633438 |
| 82 | MP0000538_abnormal_urinary_bladder | 1.15571398 |
| 83 | MP0001765_abnormal_ion_homeostasis | 1.15415213 |
| 84 | MP0000767_abnormal_smooth_muscle | 1.15395435 |
| 85 | MP0004233_abnormal_muscle_weight | 1.14461232 |
| 86 | MP0000470_abnormal_stomach_morphology | 1.14180134 |
| 87 | MP0005375_adipose_tissue_phenotype | 1.13811192 |
| 88 | MP0002909_abnormal_adrenal_gland | 1.13519512 |
| 89 | MP0000609_abnormal_liver_physiology | 1.13192050 |
| 90 | MP0002396_abnormal_hematopoietic_system | 1.12627026 |
| 91 | MP0003183_abnormal_peptide_metabolism | 1.12346087 |
| 92 | MP0005332_abnormal_amino_acid | 1.12111701 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 1.11876496 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 1.11825243 |
| 95 | MP0009931_abnormal_skin_appearance | 1.10337233 |
| 96 | MP0000627_abnormal_mammary_gland | 1.09878942 |
| 97 | MP0000427_abnormal_hair_cycle | 1.09567120 |
| 98 | MP0009672_abnormal_birth_weight | 1.08844133 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 1.08046558 |
| 100 | MP0001191_abnormal_skin_condition | 1.05551108 |
| 101 | MP0009643_abnormal_urine_homeostasis | 1.05298190 |
| 102 | MP0003693_abnormal_embryo_hatching | 1.03600512 |
| 103 | MP0000613_abnormal_salivary_gland | 1.02658245 |
| 104 | MP0002009_preneoplasia | 1.01336425 |
| 105 | MP0001881_abnormal_mammary_gland | 0.99147506 |
| 106 | MP0009697_abnormal_copulation | 0.99140315 |
| 107 | MP0003878_abnormal_ear_physiology | 0.98885789 |
| 108 | MP0005377_hearing/vestibular/ear_phenot | 0.98885789 |
| 109 | MP0005464_abnormal_platelet_physiology | 0.98681518 |
| 110 | MP0005025_abnormal_response_to | 0.95921419 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.94640587 |
| 112 | MP0005257_abnormal_intraocular_pressure | 0.94350381 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.93086241 |
| 114 | MP0001664_abnormal_digestion | 0.92400983 |
| 115 | MP0003075_altered_response_to | 0.92351478 |
| 116 | MP0002723_abnormal_immune_serum | 0.92340202 |
| 117 | MP0005023_abnormal_wound_healing | 0.92071871 |
| 118 | MP0002148_abnormal_hypersensitivity_rea | 0.91891419 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.90766811 |
| 120 | MP0005166_decreased_susceptibility_to | 0.89709782 |
| 121 | MP0000462_abnormal_digestive_system | 0.88252351 |
| 122 | MP0003300_gastrointestinal_ulcer | 0.87235918 |
| 123 | MP0008469_abnormal_protein_level | 0.87148549 |
| 124 | MP0002452_abnormal_antigen_presenting | 0.87119879 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.87061592 |
| 126 | MP0001730_embryonic_growth_arrest | 0.86582859 |
| 127 | MP0003045_fibrosis | 0.86432482 |
| 128 | MP0009764_decreased_sensitivity_to | 0.86196555 |
| 129 | MP0005000_abnormal_immune_tolerance | 0.85094283 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.84686664 |
| 131 | MP0003656_abnormal_erythrocyte_physiolo | 0.83575070 |
| 132 | MP0000733_abnormal_muscle_development | 0.83004994 |
| 133 | MP0000534_abnormal_ureter_morphology | 0.82701903 |
| 134 | MP0003690_abnormal_glial_cell | 0.81009162 |
| 135 | MP0008260_abnormal_autophagy | 0.80802924 |
| 136 | MP0009785_altered_susceptibility_to | 0.80551898 |
| 137 | MP0002736_abnormal_nociception_after | 0.78733509 |
| 138 | MP0000490_abnormal_crypts_of | 0.77900031 |
| 139 | MP0002822_catalepsy | 0.77778488 |
| 140 | MP0002136_abnormal_kidney_physiology | 0.77761670 |
| 141 | MP0000762_abnormal_tongue_morphology | 0.77026729 |
| 142 | MP0001845_abnormal_inflammatory_respons | 0.75363608 |
| 143 | MP0000003_abnormal_adipose_tissue | 0.74874443 |
| 144 | MP0003879_abnormal_hair_cell | 0.74603244 |
| 145 | MP0000249_abnormal_blood_vessel | 0.72624680 |
| 146 | MP0005647_abnormal_sex_gland | 0.72610884 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.71433160 |
| 148 | MP0005451_abnormal_body_composition | 0.70822395 |
| 149 | MP0005595_abnormal_vascular_smooth | 0.70513093 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70487324 |
| 151 | MP0002086_abnormal_extraembryonic_tissu | 0.68059697 |
| 152 | MP0004808_abnormal_hematopoietic_stem | 0.67162280 |
| 153 | MP0002420_abnormal_adaptive_immunity | 0.64780569 |
| 154 | MP0002970_abnormal_white_adipose | 0.64519352 |
| 155 | MP0000465_gastrointestinal_hemorrhage | 0.64150965 |
| 156 | MP0005058_abnormal_lysosome_morphology | 0.62096129 |
| 157 | MP0002080_prenatal_lethality | 0.61864150 |
| 158 | MP0010352_gastrointestinal_tract_polyps | 0.60565845 |
| 159 | MP0003984_embryonic_growth_retardation | 0.60236011 |
| 160 | MP0010630_abnormal_cardiac_muscle | 0.59387697 |
| 161 | MP0005448_abnormal_energy_balance | 0.59260761 |
| 162 | MP0003942_abnormal_urinary_system | 0.57279947 |
| 163 | MP0001944_abnormal_pancreas_morphology | 0.56356857 |
| 164 | MP0002088_abnormal_embryonic_growth/wei | 0.56055796 |
| 165 | MP0004510_myositis | 0.55712166 |
| 166 | MP0002111_abnormal_tail_morphology | 0.54834092 |
| 167 | MP0005380_embryogenesis_phenotype | 0.52154014 |
| 168 | MP0001672_abnormal_embryogenesis/_devel | 0.52154014 |
| 169 | MP0009053_abnormal_anal_canal | 0.51614192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 6.86305559 |
| 2 | Abnormality of the nasal mucosa (HP:0000433) | 6.72361702 |
| 3 | Hematochezia (HP:0002573) | 6.54071234 |
| 4 | Polycythemia (HP:0001901) | 5.36381312 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.12576822 |
| 6 | Flat acetabular roof (HP:0003180) | 4.83745360 |
| 7 | Broad face (HP:0000283) | 4.38371316 |
| 8 | Conjunctival telangiectasia (HP:0000524) | 4.28583849 |
| 9 | Testicular atrophy (HP:0000029) | 4.16714531 |
| 10 | Abnormality of the 1st metacarpal (HP:0010009) | 4.09050748 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 4.04434461 |
| 12 | Septate vagina (HP:0001153) | 3.91225916 |
| 13 | Hypotrichosis (HP:0001006) | 3.87041965 |
| 14 | Cerebral hemorrhage (HP:0001342) | 3.84725883 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.84141560 |
| 16 | Short 1st metacarpal (HP:0010034) | 3.83885585 |
| 17 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.83885585 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.72329663 |
| 19 | Esophageal varix (HP:0002040) | 3.60651415 |
| 20 | Nasal polyposis (HP:0100582) | 3.58893476 |
| 21 | Microcytic anemia (HP:0001935) | 3.50562699 |
| 22 | Abnormal tarsal ossification (HP:0008369) | 3.48673515 |
| 23 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.46760005 |
| 24 | Lip pit (HP:0100267) | 3.44109723 |
| 25 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.43236543 |
| 26 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.39159791 |
| 27 | Flattened epiphyses (HP:0003071) | 3.26882701 |
| 28 | Increased IgE level (HP:0003212) | 3.22487859 |
| 29 | Xanthomatosis (HP:0000991) | 3.22140631 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.16773457 |
| 31 | Abnormality of carpal bone ossification (HP:0006257) | 3.10288189 |
| 32 | Petechiae (HP:0000967) | 3.07241727 |
| 33 | White forelock (HP:0002211) | 3.06350843 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.01899484 |
| 35 | Short phalanx of the thumb (HP:0009660) | 3.01821554 |
| 36 | Pulmonary embolism (HP:0002204) | 3.00897694 |
| 37 | Amelogenesis imperfecta (HP:0000705) | 2.96841783 |
| 38 | Thin bony cortex (HP:0002753) | 2.95529656 |
| 39 | Cervical subluxation (HP:0003308) | 2.91315491 |
| 40 | Complement deficiency (HP:0004431) | 2.90010602 |
| 41 | Hyperacusis (HP:0010780) | 2.88971409 |
| 42 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.86584042 |
| 43 | Vascular calcification (HP:0004934) | 2.85265513 |
| 44 | J-shaped sella turcica (HP:0002680) | 2.82538809 |
| 45 | Joint hemorrhage (HP:0005261) | 2.81124459 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.79988918 |
| 47 | Growth hormone excess (HP:0000845) | 2.79927533 |
| 48 | Prolonged partial thromboplastin time (HP:0003645) | 2.79460684 |
| 49 | Patchy hypopigmentation of hair (HP:0011365) | 2.79200415 |
| 50 | Parakeratosis (HP:0001036) | 2.78451658 |
| 51 | Visceral angiomatosis (HP:0100761) | 2.76810402 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.75653341 |
| 53 | Germ cell neoplasia (HP:0100728) | 2.70928601 |
| 54 | Bronchomalacia (HP:0002780) | 2.67920780 |
| 55 | Hemangiomatosis (HP:0007461) | 2.66163091 |
| 56 | Microretrognathia (HP:0000308) | 2.59294218 |
| 57 | Sparse lateral eyebrow (HP:0005338) | 2.57037938 |
| 58 | Epistaxis (HP:0000421) | 2.56199477 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.55343685 |
| 60 | Pili torti (HP:0003777) | 2.55064681 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.54482017 |
| 62 | Abnormality of complement system (HP:0005339) | 2.54080257 |
| 63 | Thrombophlebitis (HP:0004418) | 2.51904868 |
| 64 | Abnormal ossification of hand bones (HP:0005921) | 2.49839647 |
| 65 | Obstructive sleep apnea (HP:0002870) | 2.49128682 |
| 66 | Hyperlipoproteinemia (HP:0010980) | 2.46931965 |
| 67 | Woolly hair (HP:0002224) | 2.44727786 |
| 68 | Ankle clonus (HP:0011448) | 2.44426777 |
| 69 | Curly hair (HP:0002212) | 2.42630270 |
| 70 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.40152121 |
| 71 | Spontaneous abortion (HP:0005268) | 2.38993213 |
| 72 | Abnormal hand bone ossification (HP:0010660) | 2.38746145 |
| 73 | Ureteral stenosis (HP:0000071) | 2.38484916 |
| 74 | Stridor (HP:0010307) | 2.37650041 |
| 75 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.36869516 |
| 76 | Congenital glaucoma (HP:0001087) | 2.36706086 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.35858234 |
| 78 | Spinal cord compression (HP:0002176) | 2.35835213 |
| 79 | Abnormal foot bone ossification (HP:0010675) | 2.33266368 |
| 80 | Milia (HP:0001056) | 2.32384413 |
| 81 | Axonal loss (HP:0003447) | 2.31304315 |
| 82 | Achilles tendon contracture (HP:0001771) | 2.31240899 |
| 83 | Epidermoid cyst (HP:0200040) | 2.30261768 |
| 84 | Bulbar palsy (HP:0001283) | 2.30040100 |
| 85 | Stroke (HP:0001297) | 2.29392579 |
| 86 | Hypobetalipoproteinemia (HP:0003563) | 2.29062223 |
| 87 | Broad metatarsal (HP:0001783) | 2.28895066 |
| 88 | Portal hypertension (HP:0001409) | 2.28718202 |
| 89 | Recurrent bronchitis (HP:0002837) | 2.25872159 |
| 90 | Poor suck (HP:0002033) | 2.24097174 |
| 91 | Pendular nystagmus (HP:0012043) | 2.23733259 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 2.22519096 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 2.21295589 |
| 94 | Onycholysis (HP:0001806) | 2.20565765 |
| 95 | Mucosal telangiectasiae (HP:0100579) | 2.17905070 |
| 96 | Abnormality of the hepatic vasculature (HP:0006707) | 2.15627590 |
| 97 | Intestinal polyposis (HP:0200008) | 2.15193296 |
| 98 | Short nail (HP:0001799) | 2.14063571 |
| 99 | Lymphangioma (HP:0100764) | 2.13928388 |
| 100 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.13201336 |
| 101 | Advanced eruption of teeth (HP:0006288) | 2.13029807 |
| 102 | Urethral obstruction (HP:0000796) | 2.12503023 |
| 103 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11828539 |
| 104 | Pruritus (HP:0000989) | 2.10780417 |
| 105 | Hypoalphalipoproteinemia (HP:0003233) | 2.10661573 |
| 106 | Ureteral obstruction (HP:0006000) | 2.10193808 |
| 107 | Pterygium (HP:0001059) | 2.10019703 |
| 108 | Testicular neoplasm (HP:0010788) | 2.09367440 |
| 109 | Abnormality of nail color (HP:0100643) | 2.09176143 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.08613266 |
| 111 | Myopathic facies (HP:0002058) | 2.08336096 |
| 112 | Hyperkalemia (HP:0002153) | 2.07543872 |
| 113 | Myokymia (HP:0002411) | 2.06802408 |
| 114 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.05745625 |
| 115 | Hyperthyroidism (HP:0000836) | 2.05559636 |
| 116 | Hypoglycemic coma (HP:0001325) | 2.03832229 |
| 117 | Abnormal vertebral ossification (HP:0100569) | 2.03478204 |
| 118 | Abnormality of the intrinsic pathway (HP:0010989) | 2.02997268 |
| 119 | Ketosis (HP:0001946) | 2.02889882 |
| 120 | Hypochromic anemia (HP:0001931) | 2.02394818 |
| 121 | 11 pairs of ribs (HP:0000878) | 2.01061079 |
| 122 | Intestinal polyp (HP:0005266) | 2.01029551 |
| 123 | Seborrheic dermatitis (HP:0001051) | 2.00496518 |
| 124 | Hypolipoproteinemia (HP:0010981) | 2.00337397 |
| 125 | Easy fatigability (HP:0003388) | 1.99756173 |
| 126 | Myocardial infarction (HP:0001658) | 1.98395173 |
| 127 | Abnormal hair laboratory examination (HP:0003328) | 1.98043211 |
| 128 | Severe visual impairment (HP:0001141) | 1.96434988 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95794656 |
| 130 | Dicarboxylic aciduria (HP:0003215) | 1.95794656 |
| 131 | Gingival bleeding (HP:0000225) | 1.93744566 |
| 132 | Plantar hyperkeratosis (HP:0007556) | 1.92724284 |
| 133 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92588734 |
| 134 | Fat malabsorption (HP:0002630) | 1.92513293 |
| 135 | Popliteal pterygium (HP:0009756) | 1.92049814 |
| 136 | Abnormality of methionine metabolism (HP:0010901) | 1.90937872 |
| 137 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90776575 |
| 138 | Deviation of the thumb (HP:0009603) | 1.90105976 |
| 139 | Dysmetric saccades (HP:0000641) | 1.88825418 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.88016353 |
| 141 | Severe short stature (HP:0003510) | 1.86905768 |
| 142 | Upper limb amyotrophy (HP:0009129) | 1.86670926 |
| 143 | Distal upper limb amyotrophy (HP:0007149) | 1.86670926 |
| 144 | Palmoplantar hyperkeratosis (HP:0000972) | 1.86193479 |
| 145 | Hyperactive renin-angiotensin system (HP:0000841) | 1.86153834 |
| 146 | Fragile nails (HP:0001808) | 1.85735697 |
| 147 | Anal stenosis (HP:0002025) | 1.85675442 |
| 148 | Gastrointestinal infarctions (HP:0005244) | 1.85472911 |
| 149 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85398092 |
| 150 | Partial duplication of the phalanx of hand (HP:0009999) | 1.85001577 |
| 151 | Long palpebral fissure (HP:0000637) | 1.84693565 |
| 152 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.84090136 |
| 153 | Partial duplication of thumb phalanx (HP:0009944) | 1.83965004 |
| 154 | Hypoparathyroidism (HP:0000829) | 1.83945883 |
| 155 | Diaphragmatic weakness (HP:0009113) | 1.82792249 |
| 156 | Micronodular cirrhosis (HP:0001413) | 1.82220752 |
| 157 | Macroorchidism (HP:0000053) | 1.81879483 |
| 158 | Alopecia of scalp (HP:0002293) | 1.81429460 |
| 159 | Hypercholesterolemia (HP:0003124) | 1.81298050 |
| 160 | Cavernous hemangioma (HP:0001048) | 1.80462230 |
| 161 | Distal lower limb amyotrophy (HP:0008944) | 1.79762184 |
| 162 | Prostate neoplasm (HP:0100787) | 1.79685151 |
| 163 | Ridged nail (HP:0001807) | 1.79394476 |
| 164 | Hypoplasia of dental enamel (HP:0006297) | 1.79218566 |
| 165 | Colon cancer (HP:0003003) | 1.79051464 |
| 166 | Patellar dislocation (HP:0002999) | 1.78801684 |
| 167 | Neonatal death (HP:0003811) | 1.78216190 |
| 168 | Elevated alkaline phosphatase (HP:0003155) | 1.77833735 |
| 169 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77795132 |
| 170 | Mesangial abnormality (HP:0001966) | 1.76235440 |
| 171 | Shallow orbits (HP:0000586) | 1.75668550 |
| 172 | Hyperparathyroidism (HP:0000843) | 1.75368703 |
| 173 | Hemoptysis (HP:0002105) | 1.75294372 |
| 174 | Bronchitis (HP:0012387) | 1.75239903 |
| 175 | Chondrocalcinosis (HP:0000934) | 1.75151036 |
| 176 | Recurrent sinusitis (HP:0011108) | 1.74152911 |
| 177 | Hyperammonemia (HP:0001987) | 1.74104681 |
| 178 | Abnormality of the gastric mucosa (HP:0004295) | 1.73425264 |
| 179 | Erythema (HP:0010783) | 1.72865020 |
| 180 | Short femoral neck (HP:0100864) | 1.72484266 |
| 181 | Aneurysm (HP:0002617) | 1.71170016 |
| 182 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71043584 |
| 183 | Hyperglycinemia (HP:0002154) | 1.70139753 |
| 184 | Stomach cancer (HP:0012126) | 1.69695922 |
| 185 | Right ventricular cardiomyopathy (HP:0011663) | 1.69455121 |
| 186 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69322652 |
| 187 | Back pain (HP:0003418) | 1.69244770 |
| 188 | Malnutrition (HP:0004395) | 1.68470141 |
| 189 | Prolonged bleeding time (HP:0003010) | 1.66710049 |
| 190 | Hypertriglyceridemia (HP:0002155) | 1.65798294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 7.60400130 |
| 2 | TGFBR1 | 6.66954205 |
| 3 | TIE1 | 4.76586706 |
| 4 | CAMK1D | 4.43741605 |
| 5 | EPHA2 | 4.43382138 |
| 6 | TAOK1 | 4.24597107 |
| 7 | SMG1 | 3.64339588 |
| 8 | STK16 | 3.60019643 |
| 9 | CAMK1G | 3.19613896 |
| 10 | NME2 | 2.69622093 |
| 11 | CDK12 | 2.59037914 |
| 12 | IRAK3 | 2.57674647 |
| 13 | TNK2 | 2.50244706 |
| 14 | BUB1 | 2.43429404 |
| 15 | BLK | 2.39488843 |
| 16 | MAP4K1 | 2.26800948 |
| 17 | PRKD2 | 2.25308596 |
| 18 | ARAF | 2.10936848 |
| 19 | MARK2 | 2.06631809 |
| 20 | LRRK2 | 2.04925586 |
| 21 | PKN2 | 2.02238229 |
| 22 | FGFR4 | 1.94949527 |
| 23 | CSF1R | 1.93782094 |
| 24 | PRKD3 | 1.91665426 |
| 25 | PIM2 | 1.88257897 |
| 26 | PRKCI | 1.88170102 |
| 27 | LMTK2 | 1.76197808 |
| 28 | RIPK4 | 1.42848644 |
| 29 | TESK1 | 1.41825021 |
| 30 | EPHB1 | 1.36481580 |
| 31 | IRAK2 | 1.34510862 |
| 32 | MAP3K10 | 1.25756446 |
| 33 | MAP3K3 | 1.24925703 |
| 34 | MAP2K6 | 1.23659298 |
| 35 | ERN1 | 1.21126126 |
| 36 | KDR | 1.18201377 |
| 37 | MTOR | 1.16205057 |
| 38 | RIPK1 | 1.13122871 |
| 39 | RPS6KA4 | 1.10701617 |
| 40 | EEF2K | 1.05120026 |
| 41 | SCYL2 | 1.04969817 |
| 42 | EPHA3 | 1.04685558 |
| 43 | MAPKAPK5 | 1.03172389 |
| 44 | SYK | 0.96550868 |
| 45 | GRK6 | 0.96126534 |
| 46 | MUSK | 0.91295171 |
| 47 | MAPKAPK3 | 0.90648898 |
| 48 | SIK1 | 0.89150385 |
| 49 | MAP2K2 | 0.88002966 |
| 50 | MET | 0.87969053 |
| 51 | TBK1 | 0.87741148 |
| 52 | HIPK2 | 0.86030242 |
| 53 | IRAK1 | 0.85838166 |
| 54 | BRD4 | 0.84452381 |
| 55 | FGR | 0.82868475 |
| 56 | MAP2K3 | 0.80481460 |
| 57 | MAPK12 | 0.80020402 |
| 58 | PRKCQ | 0.79507976 |
| 59 | PTK2B | 0.78520976 |
| 60 | PRPF4B | 0.78497576 |
| 61 | MAP2K1 | 0.78152225 |
| 62 | ICK | 0.76753582 |
| 63 | JAK1 | 0.76256466 |
| 64 | MAP3K11 | 0.76062695 |
| 65 | FES | 0.75554393 |
| 66 | STK39 | 0.75308147 |
| 67 | RPS6KB2 | 0.74247343 |
| 68 | CHUK | 0.74033988 |
| 69 | FER | 0.73778457 |
| 70 | PAK4 | 0.73770442 |
| 71 | CDK7 | 0.73129164 |
| 72 | CDK9 | 0.72511405 |
| 73 | SIK3 | 0.70143717 |
| 74 | KIT | 0.69113073 |
| 75 | BTK | 0.66826221 |
| 76 | PTK6 | 0.64517874 |
| 77 | PDK4 | 0.63249485 |
| 78 | PDK3 | 0.63249485 |
| 79 | PRKD1 | 0.63074243 |
| 80 | TYK2 | 0.63030591 |
| 81 | BCKDK | 0.61980074 |
| 82 | ALK | 0.61021916 |
| 83 | TAOK3 | 0.58979768 |
| 84 | TRIB3 | 0.57507765 |
| 85 | IKBKE | 0.56741330 |
| 86 | RPS6KA2 | 0.56574683 |
| 87 | MAP3K14 | 0.56121483 |
| 88 | RPS6KA5 | 0.56088908 |
| 89 | PRKAA1 | 0.54828507 |
| 90 | MAP3K13 | 0.54397507 |
| 91 | MAP3K2 | 0.53718986 |
| 92 | MAPK15 | 0.53717624 |
| 93 | CDK19 | 0.52808807 |
| 94 | GRK1 | 0.51860597 |
| 95 | IRAK4 | 0.50151545 |
| 96 | STK10 | 0.49744176 |
| 97 | MAP3K9 | 0.48809855 |
| 98 | BMX | 0.48466622 |
| 99 | DDR2 | 0.46068397 |
| 100 | MAPK7 | 0.45235513 |
| 101 | NLK | 0.44626857 |
| 102 | FGFR3 | 0.44040153 |
| 103 | ZAP70 | 0.43975578 |
| 104 | OXSR1 | 0.43954778 |
| 105 | MAPK8 | 0.41716166 |
| 106 | CDC42BPA | 0.41457992 |
| 107 | BRAF | 0.39727291 |
| 108 | PDK2 | 0.39261339 |
| 109 | RAF1 | 0.38466051 |
| 110 | NTRK2 | 0.38210701 |
| 111 | MAPK4 | 0.37425728 |
| 112 | ILK | 0.37344096 |
| 113 | JAK2 | 0.37214764 |
| 114 | CDK3 | 0.36662862 |
| 115 | AKT3 | 0.35416410 |
| 116 | DYRK1B | 0.35340864 |
| 117 | CSK | 0.35261473 |
| 118 | LYN | 0.34883937 |
| 119 | MAP3K1 | 0.33837590 |
| 120 | NME1 | 0.33651833 |
| 121 | AURKA | 0.33483662 |
| 122 | CAMKK1 | 0.33465057 |
| 123 | IKBKB | 0.33384933 |
| 124 | WNK4 | 0.32985347 |
| 125 | MAPK11 | 0.32906675 |
| 126 | JAK3 | 0.32885464 |
| 127 | RPS6KL1 | 0.32674743 |
| 128 | RPS6KC1 | 0.32674743 |
| 129 | LCK | 0.32145002 |
| 130 | DAPK2 | 0.31469561 |
| 131 | MAPK10 | 0.29851528 |
| 132 | TEC | 0.29397095 |
| 133 | PDK1 | 0.29279969 |
| 134 | RPS6KA6 | 0.29059049 |
| 135 | EPHB2 | 0.28836610 |
| 136 | FGFR2 | 0.28678891 |
| 137 | RET | 0.28124181 |
| 138 | CAMK1 | 0.27408323 |
| 139 | PRKG2 | 0.27332785 |
| 140 | TESK2 | 0.27322078 |
| 141 | PTK2 | 0.27287617 |
| 142 | PDGFRA | 0.26545217 |
| 143 | MST1R | 0.26283310 |
| 144 | TAOK2 | 0.26141889 |
| 145 | CSNK1G3 | 0.25803561 |
| 146 | MAP3K7 | 0.24510987 |
| 147 | LATS2 | 0.24303472 |
| 148 | ERBB4 | 0.23910505 |
| 149 | AKT2 | 0.23800764 |
| 150 | GSK3B | 0.23384664 |
| 151 | PRKCZ | 0.23148086 |
| 152 | SIK2 | 0.23042519 |
| 153 | MAP3K8 | 0.23006717 |
| 154 | PRKAA2 | 0.22803096 |
| 155 | STK11 | 0.22402741 |
| 156 | PDPK1 | 0.22068755 |
| 157 | PHKG1 | 0.21436909 |
| 158 | PHKG2 | 0.21436909 |
| 159 | RPS6KA1 | 0.20623571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17977930 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.61671984 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20915470 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.84328348 |
| 5 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.76654508 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.74995977 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.66367372 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62859641 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51961884 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47490102 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.37762964 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.36856077 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.27391894 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24104927 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20710269 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17481483 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06661592 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04392108 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99682428 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94928553 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94678676 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.89606054 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.87966244 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.87193924 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83973278 |
| 26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.80975900 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.79273436 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77858612 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.72247814 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.65366871 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58494670 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57579811 |
| 33 | Prostate cancer_Homo sapiens_hsa05215 | 1.52714206 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49951121 |
| 35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.48260001 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47108925 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46828239 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.44991827 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44028278 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.43466808 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.42563546 |
| 42 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.39487431 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39142638 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.35934076 |
| 45 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.31016604 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28567372 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.23805380 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22454418 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22342280 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19937609 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19167418 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 1.14592122 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11655076 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09794483 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07318501 |
| 56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.06632116 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06182104 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06115828 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05793524 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05558544 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.03939520 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.03836463 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02696984 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 1.02547575 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01069070 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.00196526 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00033026 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.99628056 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98587490 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98164219 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93240734 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92037599 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91956688 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91351488 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90442499 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88695894 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.87814083 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86952296 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86201507 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84693328 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84311312 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82493837 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81147162 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81137437 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78966698 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78532642 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78202940 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76992152 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74595796 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73977619 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70487769 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69614082 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67275830 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.67262917 |
| 95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67055562 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65599317 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.65512444 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65373274 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64731552 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62963225 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62118282 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.62020230 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60662519 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59947154 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.59687618 |
| 106 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58980069 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58882874 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57362418 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56486557 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55667885 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55551344 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55012048 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54881629 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.54062222 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.53776162 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53056330 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52913685 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52556710 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52459479 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50063009 |
| 121 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48080903 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.48066047 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47409225 |
| 124 | Ribosome_Homo sapiens_hsa03010 | 0.46411848 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.46127393 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45740743 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44844618 |
| 128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42869421 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41666849 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41432664 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.41155172 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40649122 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.40450966 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.39740009 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39206414 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38994339 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38783810 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37786485 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37622195 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.36483306 |
| 141 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36249979 |
| 142 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36238189 |
| 143 | Insulin secretion_Homo sapiens_hsa04911 | 0.35148546 |
| 144 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35085012 |
| 145 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34951170 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34815355 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34489099 |
| 148 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.33884740 |
| 149 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30848980 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.30612167 |
| 151 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28302399 |
| 152 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27978660 |
| 153 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27687461 |
| 154 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27622144 |
| 155 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27074270 |
| 156 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23698611 |
| 157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20888970 |
| 158 | Shigellosis_Homo sapiens_hsa05131 | 0.20128103 |
| 159 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.19462211 |
| 160 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18498899 |
| 161 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17959638 |
| 162 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17268774 |
| 163 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17056789 |
| 164 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.16402760 |
| 165 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15209272 |
| 166 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15049827 |
| 167 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14732754 |
| 168 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.13052770 |
| 169 | Influenza A_Homo sapiens_hsa05164 | 0.12699031 |

